Leveraging Prior Knowledge to Demonstrate Analytical Competency
Analytical groups are developing more methods than ever to address mounting demand for biopharmaceuticals. Still, such teams need to work within tight timelines to help candidate therapies advance quickly through clinical trials.
During a May 2022 presentation, Rajgopal Rudrarapu, an Almac Senior Scientist, pointed out that regulatory agencies allow biomanufacturers to apply prior knowledge to facilitate analytical development and validation.
